• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向线粒体以对抗非酒精性脂肪性肝病的进展。

Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease.

机构信息

Clinica Medica "A. Murri", Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy; Italian College of General Practitioners and Primary Care, Bari, Italy.

CNC Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Center for Investigation Vasco da Gama (CIVG), Department of Veterinary Medicine, Escola Universitária Vasco da Gama, Coimbra, Portugal.

出版信息

Biochem Pharmacol. 2019 Feb;160:34-45. doi: 10.1016/j.bcp.2018.11.020. Epub 2018 Nov 30.

DOI:10.1016/j.bcp.2018.11.020
PMID:
30508523
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by the excessive accumulation of triglycerides in hepatocytes. NAFLD is the most frequent chronic liver disease in developed countries, and is often associated with metabolic disorders such as obesity and type 2 diabetes. NAFLD definition encompasses a spectrum of chronic liver abnormalities, ranging from simple steatosis (NAFL), to steatohepatitis (NASH), significant liver fibrosis, cirrhosis, and hepatocellular carcinoma. NAFLD, therefore, represents a global public health issue. Mitochondrial dysfunction occurs in NAFLD, and contributes to the progression to the necro-inflammatory and fibrotic form (NASH). Disrupted mitochondrial function is associated with a decrease in the energy levels and impaired redox balance, and negatively affects cell survival by altering overall metabolism and subcellular trafficking. Such events reduce the tolerance of hepatocytes towards damaging hits, and favour the injurious effects of extra-cellular factors. Here, we discuss the role of mitochondria in NAFLD and focus on potential therapeutic approaches aimed at preserving mitochondrial function.

摘要

非酒精性脂肪性肝病(NAFLD)是一种以肝细胞内甘油三酯过度积累为特征的疾病。NAFLD 是发达国家最常见的慢性肝病,常与肥胖和 2 型糖尿病等代谢紊乱有关。NAFLD 的定义包括一系列慢性肝脏异常,从单纯性脂肪变性(NAFL)到脂肪性肝炎(NASH)、显著的肝纤维化、肝硬化和肝细胞癌。因此,NAFLD 是一个全球性的公共卫生问题。线粒体功能障碍发生在 NAFLD 中,并导致向坏死性炎症和纤维化形式(NASH)的进展。线粒体功能障碍与能量水平降低和氧化还原平衡受损有关,并通过改变整体代谢和亚细胞运输来影响细胞存活。这些事件降低了肝细胞对损伤的耐受能力,并促进了细胞外因素的损伤作用。在这里,我们讨论了线粒体在 NAFLD 中的作用,并重点介绍了旨在维持线粒体功能的潜在治疗方法。

相似文献

1
Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease.靶向线粒体以对抗非酒精性脂肪性肝病的进展。
Biochem Pharmacol. 2019 Feb;160:34-45. doi: 10.1016/j.bcp.2018.11.020. Epub 2018 Nov 30.
2
From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria.从非酒精性脂肪肝到肝细胞癌:线粒体(失)适应的故事
Biology (Basel). 2023 Apr 14;12(4):595. doi: 10.3390/biology12040595.
3
Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)背景下以线粒体为药理治疗靶点的方案
Methods Mol Biol. 2021;2310:201-246. doi: 10.1007/978-1-0716-1433-4_12.
4
Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests.线粒体的重要性:非酒精性脂肪性肝病(NAFLD)的系统方面和通过稳定同位素动态呼吸试验对肝功能的诊断评估。
Int J Mol Sci. 2021 Jul 19;22(14):7702. doi: 10.3390/ijms22147702.
5
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.非酒精性脂肪性肝病:从非酒精性脂肪性肝病到非酒精性脂肪性肝炎的进展中的基本发病机制。
Transplantation. 2019 Jan;103(1):e1-e13. doi: 10.1097/TP.0000000000002480.
6
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.脂肪酸和氧化固醇的协同作用会损害线粒体功能,并限制非酒精性脂肪性肝病进展过程中的肝脏适应能力。
Redox Biol. 2018 May;15:86-96. doi: 10.1016/j.redox.2017.11.016. Epub 2017 Dec 5.
7
The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.PDE5 抑制剂乌地那非通过改善线粒体功能改善非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2021 Jun 18;558:57-63. doi: 10.1016/j.bbrc.2021.04.038. Epub 2021 Apr 22.
8
Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的氧化应激、心磷脂与线粒体功能障碍
World J Gastroenterol. 2014 Oct 21;20(39):14205-18. doi: 10.3748/wjg.v20.i39.14205.
9
Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis.肝脏中的胆固醇负担会引起线粒体动态变化和抗细胞凋亡。
J Cell Physiol. 2019 May;234(5):7213-7223. doi: 10.1002/jcp.27474. Epub 2018 Sep 21.
10
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?非酒精性脂肪性肝病(NAFLD)。线粒体作为治疗的靶点和参与者?
Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375.

引用本文的文献

1
Hesperidin Is a Promising Nutraceutical Compound in Counteracting the Progression of NAFLD In Vitro.橙皮苷是一种有前景的营养保健品化合物,可在体外对抗非酒精性脂肪性肝病的进展。
Int J Mol Sci. 2025 Jun 21;26(13):5982. doi: 10.3390/ijms26135982.
2
Pharmacological approaches to enhance mitochondrial biogenesis: focus on PGC-1Α, AMPK, and SIRT1 in cellular health.增强线粒体生物合成的药理学方法:聚焦于细胞健康中的PGC-1Α、AMPK和SIRT1
Mol Biol Rep. 2025 Feb 28;52(1):270. doi: 10.1007/s11033-025-10368-8.
3
Peridroplet mitochondria are associated with the severity of MASLD and the prevention of MASLD by diethyldithiocarbamate.
微滴体中的线粒体与 MASLD 的严重程度有关,二乙二硫代氨基甲酸盐可预防 MASLD。
J Lipid Res. 2024 Aug;65(8):100590. doi: 10.1016/j.jlr.2024.100590. Epub 2024 Jul 7.
4
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction.线粒体功能障碍和肝细胞凋亡通过氧化应激、翻译后修饰、炎症和肠道屏障功能障碍在肝脏疾病中的作用。
Cell Mol Life Sci. 2024 Jan 12;81(1):34. doi: 10.1007/s00018-023-05061-7.
5
Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.代谢综合征:从氧化应激到相关疾病管理的叙述性综述
Antioxidants (Basel). 2023 Dec 8;12(12):2091. doi: 10.3390/antiox12122091.
6
The Roles of NFR2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases.NFR2 调节的氧化应激和线粒体质量控制在慢性肝病中的作用
Antioxidants (Basel). 2023 Oct 29;12(11):1928. doi: 10.3390/antiox12111928.
7
Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers.外周血单个核细胞中的线粒体功能障碍作为非酒精性脂肪性肝病的新型诊断工具:揭示与已知和潜在疾病生物标志物的关系
Diagnostics (Basel). 2023 Jul 13;13(14):2363. doi: 10.3390/diagnostics13142363.
8
Glucose-induced enhanced anti-oxidant activity inhibits apoptosis in goose fatty liver.葡萄糖诱导增强的抗氧化活性抑制鹅脂肪肝细胞凋亡。
J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad059.
9
Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.法尼醇 X 受体和成纤维细胞生长因子 19 的消化、代谢和治疗作用的最新进展:从胆固醇到胆汁酸信号。
Nutrients. 2022 Nov 22;14(23):4950. doi: 10.3390/nu14234950.
10
The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome.地中海饮食改善肥胖和代谢综合征实验模型中线粒体功能的潜力。
Nutrients. 2022 Jul 28;14(15):3112. doi: 10.3390/nu14153112.